🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 20 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 23/03/2011 | 6,14 | 6,33 | 6,14 | 6,33 | +3,36% | 3,15% | 156.453 |
| 22/03/2011 | 5,96 | 6,13 | 5,96 | 6,12 | +3,16% | 2,83% | 94.096 |
| 21/03/2011 | 5,90 | 5,99 | 5,90 | 5,93 | +2,26% | 1,59% | 137.217 |
| 18/03/2011 | 5,77 | 5,83 | 5,71 | 5,80 | +1,09% | 2,05% | 240.290 |
| 17/03/2011 | 5,86 | 6,11 | 5,74 | 5,74 | -0,54% | 6,38% | 209.192 |
| 16/03/2011 | 5,91 | 5,99 | 5,77 | 5,77 | -2,22% | 3,69% | 229.229 |
| 15/03/2011 | 5,91 | 6,08 | 5,88 | 5,90 | -1,56% | 3,38% | 280.204 |
| 14/03/2011 | 6,06 | 6,22 | 5,95 | 6,00 | -2,34% | 4,42% | 185.788 |
| 11/03/2011 | 6,22 | 6,22 | 6,05 | 6,14 | -1,80% | 2,71% | 183.544 |
| 10/03/2011 | 6,50 | 6,51 | 6,23 | 6,25 | -5,38% | 4,32% | 187.711 |
| 09/03/2011 | 6,68 | 6,71 | 6,61 | 6,61 | -1,21% | 1,50% | 106.600 |
| 08/03/2011 | 6,66 | 6,71 | 6,62 | 6,69 | +1,13% | 1,40% | 108.844 |
| 07/03/2011 | 6,81 | 6,81 | 6,61 | 6,61 | -2,75% | 2,93% | 130.484 |
| 04/03/2011 | 6,86 | 6,87 | 6,74 | 6,80 | -0,91% | 2,00% | 97.462 |
| 03/03/2011 | 6,89 | 6,92 | 6,83 | 6,86 | +0,64% | 1,36% | 219.611 |
| 02/03/2011 | 6,71 | 6,89 | 6,68 | 6,82 | +1,96% | 3,16% | 141.224 |
| 01/03/2011 | 6,82 | 6,91 | 6,68 | 6,69 | -1,11% | 3,29% | 279.243 |
| 28/02/2011 | 6,55 | 6,77 | 6,49 | 6,76 | +7,54% | 4,19% | 664.924 |
| 25/02/2011 | 6,24 | 6,30 | 6,21 | 6,29 | +0,90% | 1,50% | 198.451 |
| 24/02/2011 | 6,19 | 6,26 | 6,18 | 6,23 | +0,61% | 1,31% | 156.773 |
| 23/02/2011 | 6,19 | 6,24 | 6,18 | 6,19 | +0,30% | 0,91% | 237.885 |
| 22/02/2011 | 6,15 | 6,24 | 6,15 | 6,18 | -0,80% | 1,42% | 114.294 |
| 18/02/2011 | 6,30 | 6,30 | 6,19 | 6,23 | -0,70% | 1,68% | 188.192 |
| 17/02/2011 | 6,39 | 6,40 | 6,14 | 6,27 | -2,14% | 4,00% | 289.822 |
| 16/02/2011 | 5,70 | 6,43 | 5,68 | 6,41 | +12,98% | 13,14% | 370.453 |
| 15/02/2011 | 5,64 | 5,68 | 5,61 | 5,67 | +0,55% | 1,11% | 151.323 |
| 14/02/2011 | 5,61 | 5,67 | 5,61 | 5,64 | +0,22% | 1,00% | 91.531 |
| 11/02/2011 | 5,65 | 5,66 | 5,61 | 5,63 | -0,33% | 0,77% | 84.959 |
| 10/02/2011 | 5,61 | 5,66 | 5,61 | 5,65 | +0,33% | 0,89% | 91.692 |
| 09/02/2011 | 5,68 | 5,69 | 5,60 | 5,63 | -0,88% | 1,54% | 95.859 |